Bayer picks an unconventional board chair as Wenning bails amid Roundup legal woes

Bayer’s announcement of the early departure of its chairman, Werner Wenning, is not so surprising, given the ongoing legal issues surrounding Roundup, the herbicide the company was saddled with in its beleaguered 2018 acquisition of Monsanto. But Bayer’s choice for his replacement is unconventional, to be sure.